Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P02768: Variant p.Glu589Lys

Albumin
Gene: ALB
Feedback?
Variant information Variant position: help 589 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Glutamate (E) to Lysine (K) at position 589 (E589K, p.Glu589Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (E) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Polymorphism: help A variant structure of albumin could lead to increased binding of zinc resulting in an asymptomatic augmentation of zinc concentration in the blood. The sequence shown is that of variant albumin A. Additional information on the polymorphism described.
Variant description: help In Osaka-1. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 589 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 609 The length of the canonical sequence.
Location on the sequence: help KAVMDDFAAFVEKCCKADDK E TCFAEEGKKLVAASQAALGL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 25 – 609 Albumin
Domain 404 – 601 Albumin 3
Site 581 – 581 Not glycated
Site 584 – 584 Not glycated
Site 588 – 588 Not glycated
Site 598 – 598 Not glycated
Modified residue 588 – 588 N6-succinyllysine
Glycosylation 569 – 569 N-linked (Glc) (glycation) lysine; in vitro
Glycosylation 597 – 597 N-linked (Glc) (glycation) lysine; in vitro
Disulfide bond 582 – 591
Helix 588 – 590



Literature citations
Point substitutions in albumin genetic variants from Asia.
Arai K.; Madison J.; Shimuzu A.; Putnam F.W.;
Proc. Natl. Acad. Sci. U.S.A. 87:497-501(1990)
Cited for: VARIANT HONOLULU-1 PRO-24; VARIANT HONOLULU-2 GLN-24; VARIANT NAGOYA LYS-143; VARIANT NEW GUINEA ASN-337; VARIANT MANAUS-1/LAMBADI LYS-525; VARIANT FUKUOKA-1 ASN-587; VARIANT OSAKA-1 LYS-589; VARIANT OSAKA-2 LYS-594;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.